| Neutrophil Gelatinase–Associated lipocalin (NGAL) as a marker of kidney damage D Bolignano, V Donato, G Coppolino, S Campo, A Buemi, A Lacquaniti, ... American Journal of Kidney Diseases 52 (3), 595-605, 2008 | 708 | 2008 |
| Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease D Bolignano, A Lacquaniti, G Coppolino, V Donato, S Campo, MR Fazio, ... Clinical Journal of the American Society of Nephrology 4 (2), 337-344, 2009 | 635 | 2009 |
| Exercise in patients on dialysis: a multicenter, randomized clinical trial F Manfredini, F Mallamaci, G D’Arrigo, R Baggetta, D Bolignano, C Torino, ... Journal of the American Society of Nephrology 28 (4), 1259-1268, 2017 | 315 | 2017 |
| Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference A Blanchard, D Bockenhauer, D Bolignano, LA Calo, E Cosyns, ... Kidney international 91 (1), 24-33, 2017 | 265 | 2017 |
| Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients D Bolignano, A Lacquaniti, G Coppolino, V Donato, MR Fazio, G Nicocia, ... Kidney and Blood Pressure Research 32 (2), 91-98, 2009 | 265 | 2009 |
| The aging kidney revisited: a systematic review D Bolignano, F Mattace-Raso, EJG Sijbrands, C Zoccali Ageing research reviews 14, 65-80, 2014 | 254 | 2014 |
| Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene D Bolignano, V Donato, A Lacquaniti, MR Fazio, C Bono, G Coppolino, ... Cancer letters 288 (1), 10-16, 2010 | 229 | 2010 |
| Aldosterone antagonists for preventing the progression of chronic kidney disease D Bolignano, SC Palmer, SD Navaneethan, GFM Strippoli Cochrane Database of Systematic Reviews, 2014 | 222 | 2014 |
| Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients D Bolignano, G Coppolino, S Campo, C Aloisi, G Nicocia, N Frisina, ... Nephrology Dialysis Transplantation 23 (1), 414-416, 2008 | 211 | 2008 |
| Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease D Bolignano, G Coppolino, S Campo, C Aloisi, G Nicocia, N Frisina, ... American journal of nephrology 27 (4), 373-378, 2007 | 207 | 2007 |
| Effects of weight loss on renal function in obese CKD patients: a systematic review D Bolignano, C Zoccali Nephrology Dialysis Transplantation 28 (suppl_4), iv82-iv98, 2013 | 188 | 2013 |
| Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease D Bolignano, A Lacquaniti, G Coppolino, S Campo, A Arena, M Buemi Kidney and Blood Pressure Research 31 (4), 255-258, 2008 | 180 | 2008 |
| Renal biopsy in 2015-from epidemiology to evidence-based indications M Fiorentino, D Bolignano, V Tesar, A Pisano, W Van Biesen, G Tripepi, ... American journal of nephrology 43 (1), 1-19, 2016 | 174 | 2016 |
| Pulmonary hypertension in CKD D Bolignano, S Rastelli, R Agarwal, D Fliser, Z Massy, A Ortiz, A Wiecek, ... American journal of kidney diseases 61 (4), 612-622, 2013 | 172 | 2013 |
| Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure D Bolignano, G Basile, P Parisi, G Coppolino, G Nicocia, M Buemi Rejuvenation research 12 (1), 7-14, 2009 | 155 | 2009 |
| Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review S Abd ElHafeez, D Bolignano, G D’Arrigo, E Dounousi, G Tripepi, ... BMJ open 8 (1), e015069, 2018 | 150 | 2018 |
| Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR< 45 mL/min) Guideline Development Group, H Bilo, L Coentrão, C Couchoud, A Covic, ... Nephrology Dialysis Transplantation 30 (suppl_2), ii1-ii142, 2015 | 150 | 2015 |
| Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies M Fiorentino, D Bolignano, V Tesar, A Pisano, WV Biesen, G Tripepi, ... Nephrology Dialysis Transplantation 32 (1), 97-110, 2017 | 140 | 2017 |
| Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology D Bolignano, A Cabassi, E Fiaccadori, E Ghigo, R Pasquali, A Peracino, ... Clinical Chemistry and Laboratory Medicine (CCLM) 52 (10), 1447-1456, 2014 | 139 | 2014 |
| Paricalcitol and endothelial function in chronic kidney disease trial C Zoccali, G Curatola, V Panuccio, R Tripepi, P Pizzini, M Versace, ... Hypertension 64 (5), 1005-1011, 2014 | 124 | 2014 |
